Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

Formation Bio

We are excited to announce our collaboration with OpenAI and Sanofi to build fine-tuned and custom AI solutions to transform drug development. Since our inception, we have focused on building a pharma company differentiated by radical efficiency throughout drug development and clinical trials - and this collaboration helps us advance that vision. 
 
As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently.

You can read more about the collaboration here: https://lnkd.in/eYx9_QYg
#ai #drugdevelopment #clinicaltrials #pharma #biotech

Formation Bio will be attending PharmaSUG 2024! Our team members Helena Belloff Melanie Hullings Andrew Burd Emily Murphy Laura Fazio, MS will be presenting on May 20th and 21st - we hope to see you there! Details below. 

#software #datascience #pharma #biotech #conference #baltimore #statisticalprogramming #research #clinicaldevelopment #PharmaSUG2024

We have had an exciting Q1 at Formation Bio! We are thrilled to introduce our newest team members Amanda Hyler, Jamie C., Marianne Hawes, Joseph St.Amand, Gina DiGello, Benjamin Miles, Debra Wallace, and Jennifer Kang.

In honor of Women's Heritage Month, the Women's Employee Resource Group at Formation Bio - a tech-driven drug development company - is hosting a virtual event for young women interested in learning more about pursuing STEM fields on March 20th at 5 PM EST . We hope to inspire and empower young women by providing them with insights and guidance opportunities from successful women professionals at our organization. If you're interested in attending, please fill out this form so we can send you the Zoom links! #womensupportingwomen  #equality  #stem 

Sign up - https://lnkd.in/eVxmfe3D

Exscientia is a company founded in 2012 that has developed an AI-powered design platform called Centaur Chemist, which identifies potential new drugs.

Exscientia

Gen AI is a technology showcased in the context of healthcare and pharma, accelerating analysis and supporting strategic decision-making, particularly impacting the efficiency of clinical trials.

Gen AI

Formation Bio is a biotechnology company that leverages artificial intelligence and technology to streamline the drug development process. The company aims to address the inefficiencies in clinical trials, which are a major bottleneck in bringing new treatments to patients. By integrating expertise from both the tech and pharmaceutical industries, Formation Bio seeks to accelerate the creation and approval of new drugs, making treatments more accessible and reducing healthcare costs.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 2, 2024 6:30 AM	0775a7aa
public peers	general	Jul 1, 2024 8:21 AM	4eace13a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 1, 2024 8:29 AM	4df91c85
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 1, 2024 8:21 AM	7f0d6e73
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jul 1, 2024 8:21 AM	908e875b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BIO:FORMATION

Formation Bio